S.BarkhofF.ChalkiasS.ChenT.CohenS.et al
Ussher JR, Baggio LL, Campbell JE, Mulvihill EE, Kim M, Kabir MG, et al
Some doctors prescribed Ozempic or other GLP-1 drugs off-label for weight loss to non-diabetic patients or even pediatric patients, without FDA approval and without giving adequate warnings about the risks
The extract also contains a moderate amount of caffeine, which can enhance metabolic rate, increase energy expenditure, and support mental focus during exercise
99% COA supported RUO CAS 2375614-45-8 Molecular weight 3962.4 g/mol Storage -20C recommended (research-only) Package sizes 1 5 mg vial Description Cagrilintide 5 mg research overview Cagrilintide amylin analogue for metabolic and satiety-pathway research